[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: US Federal Research Public Access Act of 2006
- To: <liblicense-l@lists.yale.edu>
- Subject: RE: US Federal Research Public Access Act of 2006
- From: "Klein, Bonnie CIV DTIC O" <BKlein@DTIC.MIL>
- Date: Tue, 9 May 2006 19:54:05 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
I believe the term "Public" is used in the bill in its broadest sense. This is not a flaw in its language. The "Public" includes researchers, academics, corporations, small businesses and, yes, anyone who can access information online. The whole point is to make federally funded information available to all citizens, not just those who have an affiliation with an institution that can afford subscriptions. It is arrogant and self-serving to think that only a scientist would have an interest and the intelligence to exploit reported findings. There is anecdotal evidence of average citizens reading, understanding and fostering new avenues of inquiry based on their study of the research literature. One such individual is Sharon Terry, founder of the Genetic Alliance http://www.geneticalliance.org/ws_display.asp?filter=about_who_we_are_st aff_sterry. Her personal story of her struggle to gain access to the research about her children's disease is an example of a member of the "Public" who persevered and gained the expertise to push the boundaries of science. The "Public" also includes other sectors, including support to USG initiatives such as the Small Business Innovation Research Program. http://www.sba.gov/sbir/ "SBIR targets the entrepreneurial sector because that is where most innovation and innovators thrive. However, the risk and expense of conducting serious R&D efforts are often beyond the means of many small businesses... A major objective of the U.S. Small Business Innovation Research program is to produce new high technology products and services from federal research and development. In the early years of the program, it was believed that very little federal R & D would result in spin-off commercialized products and services. The program, however, has produced a stream of innovations far exceeding early expectations. It is now estimated based on a continuing study of commercialization, that over 39% of Phase II projects will result in a commercialized product or service. These innovations cover the entire high technology spectrum." Finally take a look at "Scientific and Technical Information: a Commodity or a Public Good?" By Harold M. Schoolman, U. S. National Library of Medicine Published in the ICSTI Forum, Quarterly Newsletter of the International Council for Scientific and Technical Information, No30, April 1999 http://www.icsti.org/forum/30/index.html#schoolman . We've had this discussion before. Bonnie Klein -----Original Message----- [mailto:owner-liblicense-l@lists.yale.edu] On Behalf Of Stevan Harnad Sent: Monday, May 08, 2006 7:09 PM To: AmSci Forum Subject: Re: US Federal Research Public Access Act of 2006 ** Apologies for Cross-Posting ** As presently drafted, the wording of the the timely and extremely welcome US Federal Research Public Access Act (FRPAA) http://cornyn.senate.gov/doc_archive/05-02-2006_COE06461_xml.pdf stands to create needless problems for itself that could even make it fail under the already-gathering opposition from the publisher lobby: http://www.nytimes.com/2006/05/08/business/media/08journal.html?_r=1&adx nnl=1&oref=slogin&adxnnlx=1147107814-LFLCRUGWHIqcRqKhm1BhhQ Yet the FRPAA's flaws are ever so easily correctable: The gist of the problem is all there in this well-meaning quote by Senator John Cornyn (R, co-sponsor of the bill (with Senator Joe Lieberman, D: quotation is from Robin Peek's Newsbreak in Information Today): http://www.infotoday.com/newsbreaks/nb060508-2.shtml > JC: "Making this information available to the public will lead > to faster discoveries, innovations and cures"..." This same logic underlies the Bill itself. The publisher lobby will (quite rightly) jump straight onto the two profound errors in this reasoning, and they will use it, for all its worth, against the Bill: (1) For most of the research literature, the public has neither the expertise nor the interest to read it. (2) Making it accessible to the public, does not make for cures! [SNIP]
- Prev by Date: RE: BMC in LJ Academic NewsWire
- Next by Date: Re: NYT on Cornyn-Lieberman
- Previous by thread: Re: US Federal Research Public Access Act of 2006
- Next by thread: Re: Dramatic Growth of Open Access
- Index(es):